• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[III 期淋巴肉芽肿病放化疗的预后因素]

[Prognostic factors in the chemoradiation treatment of III-stage lymphogranulomatosis].

作者信息

Kanaev S V, Kholin A V, Gershanovich M L, Malinin A P, Semenov I I

出版信息

Med Radiol (Mosk). 1988 Jul;33(7):40-6.

PMID:3398754
Abstract

The results of therapy of 152 patients with stage III Hodgkin's disease (106--IIIA, 46--IIIB) were studied. The administration of 2-4 cycles of polychemotherapy (MOPP scheme including embichin, vincristine, procarbazine and prednisolone) followed by large field irradiation after a radical program in 2-4 weeks was envisaged in the therapeutic plan. Cox's multifactor regression analysis made it possible to determine the values of some indices for the outcome of disease. The main prognostic factors in chemo- and radiotherapy were a histological type and mediastinal lymph node involvement. The fact of the involvement of the mediastinal lymph nodes in a tumor process rather than a degree of their enlargement played a decisive role. Such prognostic factors as male sex and the age over 40 were regarded as unfavorable, however their role was not as important as that of a histological type and mediastinal lymph node involvement. The above program of chemo- and radiotherapy made it possible to reduce the effect of general symptoms and signs of "biological activity" of a process.

摘要

对152例III期霍奇金病患者(106例为IIIA期,46例为IIIB期)的治疗结果进行了研究。治疗方案设想在2 - 4周内进行根治性治疗后给予2 - 4周期的多药化疗(MOPP方案,包括氮芥、长春新碱、丙卡巴肼和泼尼松龙),随后进行大野照射。Cox多因素回归分析使得确定疾病预后的一些指标值成为可能。化疗和放疗中的主要预后因素是组织学类型和纵隔淋巴结受累情况。纵隔淋巴结在肿瘤过程中的受累事实而非其肿大程度起决定性作用。男性性别和40岁以上等预后因素被视为不利因素,但其作用不如组织学类型和纵隔淋巴结受累情况重要。上述化疗和放疗方案能够减轻疾病“生物活性”的一般症状和体征。

相似文献

1
[Prognostic factors in the chemoradiation treatment of III-stage lymphogranulomatosis].[III 期淋巴肉芽肿病放化疗的预后因素]
Med Radiol (Mosk). 1988 Jul;33(7):40-6.
2
Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.临床I期或II期霍奇金淋巴瘤的综合治疗:欧洲癌症研究与治疗组织H7随机对照试验的长期结果
J Clin Oncol. 2006 Jul 1;24(19):3128-35. doi: 10.1200/JCO.2005.05.2746. Epub 2006 Jun 5.
3
[The role of radiotherapy in the treatment of Stage IIIA Hodgkin's disease in children].[放射治疗在儿童ⅢA期霍奇金病治疗中的作用]
Vopr Onkol. 1986;32(9):53-6.
4
[Evaluation of the effectiveness of chemoradiotherapy of stage IIIA Hodgkin's disease].[ⅢA期霍奇金淋巴瘤放化疗效果评估]
Med Radiol (Mosk). 1987 May;32(5):16-21.
5
[Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy].
Ter Arkh. 2006;78(8):57-62.
6
[A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].[某放疗诊所霍奇金病治疗结果的回顾性分析]
Strahlenther Onkol. 1994 Sep;170(9):516-23.
7
Pediatric Hodgkin's disease.小儿霍奇金病
J Ky Med Assoc. 2004 Mar;102(3):104-6.
8
CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL).环磷酰胺、长春花碱、丙卡巴肼和泼尼松(CVPP)联合扩大野放疗治疗早期预后不良的霍奇金病。一项代表意大利淋巴瘤研究组(GISL)开展的前瞻性研究。
Haematologica. 1996 Nov-Dec;81(6):503-12.
9
Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.单纯化疗或综合治疗小儿霍奇金病
Radiat Oncol Investig. 1999;7(6):365-73. doi: 10.1002/(SICI)1520-6823(1999)7:6<365::AID-ROI7>3.0.CO;2-W.
10
Stage I and II Hodgkin's disease: involved-field radiotherapy versus extended-field radiotherapy versus involved-field radiotherapy followed by six cycles of MOPP.I期和II期霍奇金病:累及野放疗与扩大野放疗对比累及野放疗后进行六个周期的MOPP方案化疗
Cancer Treat Rep. 1982 Apr;66(4):789-98.